Steven Hartford
Glendale, CANPI 1215904099
Payments from drug & device makers
$5,968in general payments, 2019–2025
Across 103 payments — averaging $57.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Therapeuticsmd, Inc.$246
- Boston Scientific$184
- Davol Inc.$152
- Bayer$123
- Hologic Sales And Service, LLC$98
- plus $588 from 15 others
What the payments were for
- Speaking & faculty fees$2,80047%
- Travel & lodging$69712%
- Food & beverage$2,41640%
- Education$541%
General payments by program year
19
20
21
22
23
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 48 | $4,575 |
| Therapeuticsmd, Inc. | 9 | $246 |
| Boston Scientific | 2 | $184 |
| Davol Inc. | 2 | $152 |
| Bayer | 5 | $123 |
| Hologic Sales And Service, LLC | 5 | $98 |
| Myovant Sciences Inc. | 6 | $95 |
| Pfizer | 4 | $87 |
| Roche Diagnostics Corporation | 3 | $65 |
| AMAG Pharmaceuticals, Inc. | 3 | $54 |
| Evofem Biosciences, Inc. | 3 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| Astellas Pharma US Inc | 2 | $40 |
| Ascend Therapeutics US, LLC | 2 | $35 |
| Mayne Pharma Commercial LLC | 1 | $30 |
| Coopersurgical, Inc. | 1 | $19 |
| Mission Pharmacal Company | 1 | $17 |
| Mycovia Pharmaceuticals, Inc. | 1 | $17 |
| Duchesnay USA Incorporated | 1 | $16 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
| Lupin Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$3,768
- Varithena Administration Pack$167
- PROGEL$102
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 33 | $3,106 |
| YuvafemEstradiol | 13 | $2,080 |
| Estradiol (Twice Weekly)Estradiol | 17 | $1,556 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 13 | $960 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.